A systematic review of GWAS identified SNPs associated with outcomes of medications for opioid use disorder

BACKGROUND: Patients with opioid use disorder (OUD) display an interindividual variability in their response to medications for opioid use disorder (MOUD). A genetic basis may explain the variability in this response. However, no consensus has been reached regarding which genetic variants significan...

Descripción completa

Detalles Bibliográficos
Autores principales: Chawar, Caroul, Hillmer, Alannah, Sanger, Stephanie, D’Elia, Alessia, Panesar, Balpreet, Guan, Lucy, Xie, Dave Xiaofei, Bansal, Nandini, Abdullah, Aamna, Kapczinski, Flavio, Pare, Guillaume, Thabane, Lehana, Samaan, Zainab
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627063/
https://www.ncbi.nlm.nih.gov/pubmed/34838141
http://dx.doi.org/10.1186/s13722-021-00278-y

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8627063/
https://www.ncbi.nlm.nih.gov/pubmed/34838141
http://dx.doi.org/10.1186/s13722-021-00278-y

Ejemplares similares